Alpna Seth is the founder of Nura Bio. Nura Bio has raised $141M in total funding. Latest round: Series A. Based in South San Francisco, United States.
Alpna Seth, PhD, is the President and CEO of Nura Bio, a biopharmaceutical company focused on discovering and developing neuroprotective drugs to treat acute and chronic neurological diseases. The company launched with a $73 million Series A financing led by The Column Group in 2020, and has since raised additional funding. Prior to Nura Bio, Dr. Seth served as Chief Operating Officer of Vir Biotechnology and held senior executive roles at Biogen for two decades, including Senior Vice President and Global Head of Biogen's Biosimilars Business Unit.
Full founder directory · Investor directory · Company funding database · Fundraising library